scholarly article | Q13442814 |
P50 | author | Martha Torres | Q77437183 |
Claudia Carranza | Q88769013 | ||
P2093 | author name string | Rogelio Hernandez-Pando | |
Bruno Rivas-Santiago | |||
Eduardo Sada | |||
Diana Aguilar-Leon | |||
Juan Leon Contreras | |||
Esmeralda Juarez | |||
P2860 | cites work | Interaction of pathogenic mycobacteria with the host immune system | Q22252359 |
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein | Q24682905 | ||
Epithelial antimicrobial peptides in host defense against infection | Q24791605 | ||
Antimicrobial peptides of multicellular organisms | Q28131811 | ||
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project | Q28145755 | ||
LL-37, the only human member of the cathelicidin family of antimicrobial peptides | Q28241675 | ||
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection | Q28244066 | ||
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response | Q28298985 | ||
Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis | Q28346140 | ||
Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection. | Q33591272 | ||
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils | Q33695688 | ||
Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model | Q33849677 | ||
Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells | Q33946746 | ||
Correlates of protective immunity to Mycobacterium tuberculosis in humans | Q33956267 | ||
Innate antimicrobial peptide protects the skin from invasive bacterial infection | Q34102960 | ||
Host antimicrobial defence peptides in human disease | Q34557523 | ||
Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic | Q34694936 | ||
Cathelicidins and Innate Defense Against Invasive Bacterial Infection | Q35585098 | ||
Toll-like receptor pathways in the immune responses to mycobacteria | Q35862734 | ||
Neutrophil-mediated innate immune resistance to mycobacteria | Q35865371 | ||
Update in tuberculosis 2005. | Q36403165 | ||
Tuberculosis: back on the immunologists' agenda | Q36450881 | ||
Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication | Q36602184 | ||
Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts | Q37144577 | ||
Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. | Q37700302 | ||
Microbial DNA induces a host defense reaction of human respiratory epithelial cells | Q38339218 | ||
The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial ce | Q39653495 | ||
Endogenous antimicrobial peptides and skin infections in atopic dermatitis | Q40698186 | ||
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses | Q40702297 | ||
Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. | Q40928245 | ||
Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosis | Q42489556 | ||
Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens | Q43646136 | ||
Antimicrobial peptides in the innate immunity of infectious diseases | Q44129327 | ||
Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli | Q46961436 | ||
Expression of human beta defensin (HBD-1 and HBD-2) mRNA in nasal epithelia of adult cystic fibrosis patients, healthy individuals, and individuals with acute cold. | Q51727354 | ||
Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. | Q55036173 | ||
Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator | Q57940216 | ||
Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells | Q62734176 | ||
Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis | Q71764410 | ||
Innate immunity to Mycobacterium tuberculosis | Q73805385 | ||
[Neutrophil participation in early control and immune activation during experimental pulmonary tuberculosis] | Q79191668 | ||
beta-Defensin gene expression during the course of experimental tuberculosis infection | Q80082567 | ||
[Cell immunity response in human pulmonary tuberculosis. Review] | Q81625412 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mycobacterium tuberculosis | Q130971 |
P304 | page(s) | 935-941 | |
P577 | publication date | 2007-12-26 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells | |
P478 | volume | 76 |